During the past decade, Austin Heart Clinical Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Austin Heart Clinical Research" are "Critical Limb Ischemia (CLI)" (1 trials) and "Heart Failure" (1 trials). Many other conditions were trialed in "Austin Heart Clinical Research" in a lesser frequency.

Most popular intervention types in "Austin Heart Clinical Research" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin 10 mg Tab" (1 trials), "PLX-PAD" (1 trials), "Placebo" (1 trials) and "Placebo Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Austin Heart Clinical Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Austin Heart Clinical Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Austin Heart Clinical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Austin Heart Clinical Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".